Stephen Williamson
Net Worth

Last updated:

What is Stephen Williamson net worth?

The estimated net worth of Mr. Stephen Williamson is at least $118,131,034 as of 13 May 2024. He owns shares worth $18,030,734 as insider, has earned $68,060,300 from insider trading and has received compensation worth at least $32,040,000 in Thermo Fisher Scientific Inc..

What is the salary of Stephen Williamson?

Mr. Stephen Williamson salary is $3,560,000 per year as Senior Vice President & Chief Financial Officer in Thermo Fisher Scientific Inc..

How old is Stephen Williamson?

Mr. Stephen Williamson is 58 years old, born in 1967.

What stocks does Stephen Williamson currently own?

As insider, Mr. Stephen Williamson owns shares in one company:

Company Title Shares Price per share Total value
Thermo Fisher Scientific Inc. (TMO) Senior Vice President & Chief Financial Officer 36,481 $494.25 $18,030,734

What does Thermo Fisher Scientific Inc. do?

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

TMO logo
TMO
Thermo Fisher Scientific Inc.
$494.25

Stephen Williamson insider trading

Thermo Fisher Scientific Inc.

Mr. Stephen Williamson has made 31 insider trades between 2016-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 22,550 units of TMO stock on 2 Nov 2021. As of 13 May 2024 he still owns at least 36,481 units of TMO stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 21,925 $210.68 $4,619,159
Option
Common Stock 21,925 $210.68 $4,619,159
Sale
Common Stock 21,925 $591.27 $12,963,595
Option
Stock Option (Right to Buy) 14,100 $190.59 $2,687,319
Sale
Common Stock 14,100 $550 $7,755,000
Option
Common Stock 14,100 $190.59 $2,687,319
Option
Stock Option (Right to Buy) 15,000 $190.59 $2,858,850
Sale
Common Stock 15,000 $557.42 $8,361,300
Option
Common Stock 15,000 $190.59 $2,858,850
Option
Stock Option (Right to Buy) 15,000 $157.68 $2,365,200
Sale
Common Stock 500 $600.62 $300,310
Option
Common Stock 12,300 $157.68 $1,939,464
Sale
Common Stock 1,652 $602.6 $995,495
Sale
Common Stock 5,484 $603.56 $3,309,923
Sale
Common Stock 2,444 $604.7 $1,477,887
Sale
Common Stock 880 $605.61 $532,937
Sale
Common Stock 40 $606.21 $24,248
Option
Stock Option (Right to Buy) 12,300 $157.68 $1,939,464
Sale
Common Stock 1,300 $601.53 $781,989
Sale
Common Stock 7,800 $600.29 $4,682,262
Option
Common Stock 15,000 $157.68 $2,365,200
Sale
Common Stock 3,316 $602.67 $1,998,454
Sale
Common Stock 1,384 $603.34 $835,023
Sale
Common Stock 2,500 $601.63 $1,504,075
Sale
Common Stock 22,550 $638.28 $14,393,191
Option
Stock Option (Right to Buy) 22,550 $129.77 $2,926,314
Option
Common Stock 22,550 $129.77 $2,926,314
Option
Stock Option (Right to Buy) 19,800 N/A N/A
Option
Common Stock 19,800 N/A N/A
Sale
Common Stock 19,800 N/A N/A
Sale
Common Stock 19,800 $411.34 $8,144,611
Sale
Common Stock 2,500 N/A N/A
Option
Stock Option (Right to Buy) 8,700 N/A N/A
Option
Common Stock 8,700 N/A N/A
Sale
Common Stock 8,700 N/A N/A
Sale
Common Stock 2,500 N/A N/A
Sale
Common Stock 3,268 N/A N/A
Sale
Common Stock 2,500 N/A N/A
Sale
Common Stock 2,500 N/A N/A
Option
Stock Option (Right to Buy) 9,500 N/A N/A
Sale
Common Stock 9,500 N/A N/A
Option
Common Stock 9,500 N/A N/A
Sale
Common Stock 2,500 N/A N/A
Sale
Common Stock 2,500 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 2,500 N/A N/A
Sale
Common Stock 2,500 N/A N/A
Option
Stock Option (Right to Buy) 3,740 N/A N/A
Option
Common Stock 3,740 N/A N/A
Option
Common Stock 8,660 N/A N/A
Sale
Common Stock 8,660 N/A N/A
Option
Stock Option (Right to Buy) 8,660 N/A N/A
Option
Common Stock 4,592 N/A N/A
Option
Stock Option (Right to Buy) 2,915 N/A N/A
Sale
Common Stock 10,708 N/A N/A
Option
Stock Option (Right to Buy) 10,708 N/A N/A
Option
Common Stock 10,708 N/A N/A